← Mechanisms of action

TNFRSF9

SINGLE PROTEINHomo sapiens
Preferred name: Tumor necrosis factor receptor superfamily member 9 ChEMBL ↗

Linked proteins

Drugs acting on this target (67)

Active Pharmaceutical Ingredient Mechanism Type Approval Status API Type Mechanism of Action
ap601ActivatorexperimentalmAbTNFRSF9 activator
adg206AgonistexperimentalmAbCD137
bi 765179AgonistexperimentalSmall moleculeTNFRSF9 agonist
lbl-024AgonistexperimentalSmall moleculeTNFRSF9 agonist
ro7122290AgonistexperimentalmAbTNFRSF9 agonist
twp-101AgonistexperimentalmAbTNFRSF9 agonist
urelumabAgonistexperimentalmAbTNFRSF9 agonist
utomilumabAgonistexperimentalmAbTNFRSF9 agonist
abl503AntagonistexperimentalmAbTNFRSF9 antagonist
actr087AntagonistexperimentalCell therapyTNFRSF9 antagonist
atg-101AntagonistexperimentalmAbTNFRSF9 antagonist
cb307AntagonistexperimentalmAbTNFRSF9 antagonist
eu101AntagonistexperimentalmAbTNFRSF9 antagonist
FS-222AntagonistexperimentalmAbCD137
fs222AntagonistexperimentalmAbTNFRSF9 antagonist
gnc-035AntagonistexperimentalmAbTNFRSF9 antagonist
gnc-038AntagonistexperimentalmAbTNFRSF9 antagonist
gnc-039AntagonistexperimentalmAbTNFRSF9 antagonist
hbm 7008AntagonistexperimentalmAbTNFRSF9 antagonist
hlx35AntagonistexperimentalmAbTNFRSF9 antagonist
hot-1030AntagonistexperimentalmAbTNFRSF9 antagonist
IBI319AntagonistexperimentalmAbCD137
prs-344AntagonistexperimentalmAbTNFRSF9 antagonist
qlf31907AntagonistexperimentalmAbTNFRSF9 antagonist
s095012AntagonistexperimentalmAbTNFRSF9 antagonist
tj033721AntagonistexperimentalmAbTNFRSF9 antagonist
yh004AntagonistexperimentalmAbTNFRSF9 antagonist
yh32367AntagonistexperimentalmAbTNFRSF9 antagonist
cb307Binding agentexperimentalmAbCD137
cd137l-dc-ebv-vaxImmunity, activeexperimentalVaccineTNFRSF9 immunity, active
4-1bb selected tilImmunity, passiveexperimentalCell therapyTNFRSF9 immunity, passive
cd137 car-t cellsImmunity, passiveexperimentalCell therapyTNFRSF9 immunity, passive
wu-cart-007Immunity, passiveexperimentalCell therapyTNFRSF9 immunity, passive
abl103InhibitorexperimentalmAbTNFRSF9 inhibitor
adg106InhibitorexperimentalmAbTNFRSF9 inhibitor
agen2373InhibitorexperimentalmAbTNFRSF9 inhibitor
alg.apv-527InhibitorexperimentalmAbTNFRSF9 inhibitor
alps12InhibitorexperimentalmAbTNFRSF9 inhibitor
ap203InhibitorexperimentalmAbTNFRSF9 inhibitor
ator-1017InhibitorexperimentalmAbTNFRSF9 inhibitor
bgb-b167InhibitorexperimentalmAbTNFRSF9 inhibitor
BNT314InhibitorexperimentalmAbTNFRSF9 inhibitor
bt7480InhibitorexperimentalRecombinant proteinTNFRSF9 inhibitor
ctx-471InhibitorexperimentalmAbTNFRSF9 inhibitor
dsp107InhibitorexperimentalRecombinant proteinTNFRSF9 inhibitor
es101InhibitorexperimentalmAbTNFRSF9 inhibitor
fs120InhibitorexperimentalmAbTNFRSF9 inhibitor
ftl008.16InhibitorexperimentalmAbTNFRSF9 inhibitor
gen1042InhibitorexperimentalmAbTNFRSF9 inhibitor
gen1046InhibitorexperimentalmAbTNFRSF9 inhibitor
gen1056InhibitorexperimentalmAbTNFRSF9 inhibitor
inbrx-105InhibitorexperimentalmAbTNFRSF9 inhibitor
lvgn6051InhibitorexperimentalmAbTNFRSF9 inhibitor
mcla-145InhibitorexperimentalmAbTNFRSF9 inhibitor
mdx2003InhibitorexperimentalmAbTNFRSF9 inhibitor
mdx2004InhibitorexperimentalmAbTNFRSF9 inhibitor
mp0310InhibitorexperimentalRecombinant proteinTNFRSF9 inhibitor
nbl-028InhibitorexperimentalmAbTNFRSF9 inhibitor
nm21-1480InhibitorexperimentalmAbTNFRSF9 inhibitor
pe0116InhibitorexperimentalmAbTNFRSF9 inhibitor
pm1003InhibitorexperimentalmAbTNFRSF9 inhibitor
pm1032InhibitorexperimentalmAbTNFRSF9 inhibitor
prizloncabtagene autoleucelInhibitorexperimentalCell therapyTNFRSF9 inhibitor
prs-343InhibitorexperimentalmAbTNFRSF9 inhibitor
ro7227166InhibitorexperimentalmAbTNFRSF9 inhibitor
urelumabInhibitorexperimentalmAbTNFRSF9 inhibitor
utomilumabInhibitorexperimentalmAbTNFRSF9 inhibitor